(Q33277431)

25 July 2017

title

Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services (English)

1 reference

25 July 2017

1 reference

1 reference

6

Holly Hagan

0 references

Shiela M Strauss

object named as

Shiela M Strauss

1

0 references

Don C Des Jarlais

4

object named as

Don C Des Jarlais

1 reference

25 July 2017

author name string

Janetta Astone-Twerell

2

1 reference

25 July 2017

Corrine E Munoz-Plaza

3

1 reference

25 July 2017

Marya Gwadz

5

1 reference

25 July 2017

Andrew Osborne

7

1 reference

25 July 2017

Andrew Rosenblum

8

1 reference

25 July 2017

publication date

8 March 2007

1 reference

BMC Health Services Research

25 July 2017

published in

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

39

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Hepatitis C treatment update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Prevention and treatment of hepatitis C in injection drug users

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Course and outcome of hepatitis C

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Hepatitis C and substance use in a sample of homeless people in New York City

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Hepatitis C among noninjecting drug users: a report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Hepatitis C virus: epidemiology and transmission

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1831471

Survey of hepatitis B and C in addiction treatment unit.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

Gaps in the drug-free and methadone treatment program response to Hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

Provision of hepatitis C education in a nationwide sample of drug treatment programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

Hepatitis C knowledge among staff in U.S. drug treatment programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

Prevention and treatment of hepatitis C in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-39

A nationwide survey of hepatitis C services provided by drug treatment programs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17346346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Former addicts face barriers to treatment for HCV

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17346346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Knowledge of hepatitis among active drug injectors at a syringe exchange program

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17346346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6963-7-39

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference